Characteristics of the study women (N = 635).

IQR, interquartile range; HAART, highly active antiretroviral therapy.aHCV status was determined at enrollment. Follow-up HCV RNA testing was conducted on all women who were HCVAb+ at enrollment and HCV RNA status was 100% concordant between enrollment and follow-up testing (see Laboratory Methods).bFour women had missing CD4+ data at their CMV testing visit.cUntreated: no receipt of HAART; Treated and aviremic: undetectable HIV RNA for ≥50% of study visits following first reported receipt of HAART; Treated and viremic: HIV RNA levels above the lower level of detection for >50% of study visits following first reported receipt of HAART.